These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25041074)

  • 1. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography.
    von Seth E; Arnelo U; Enochsson L; Bergquist A
    Liver Int; 2015 Jan; 35(1):254-62. PubMed ID: 25041074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.
    Bangarulingam SY; Gossard AA; Petersen BT; Ott BJ; Lindor KD
    Am J Gastroenterol; 2009 Apr; 104(4):855-60. PubMed ID: 19259076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for complications of ERCP in primary sclerosing cholangitis.
    Ismail S; Kylänpää L; Mustonen H; Halttunen J; Lindström O; Jokelainen K; Udd M; Färkkilä M
    Endoscopy; 2012 Dec; 44(12):1133-8. PubMed ID: 23108808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
    Natt N; Michael F; Michael H; Dubois S; Al Mazrou'i A
    Can J Gastroenterol Hepatol; 2022; 2022():2372257. PubMed ID: 35910039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERCP-related adverse events in patients with primary sclerosing cholangitis.
    Navaneethan U; Jegadeesan R; Nayak S; Lourdusamy V; Sanaka MR; Vargo JJ; Parsi MA
    Gastrointest Endosc; 2015 Feb; 81(2):410-9. PubMed ID: 25085336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography.
    Koskensalo V; Tenca A; Udd M; Lindström O; Rainio M; Jokelainen K; Kylänpää L; Färkkilä M
    United European Gastroenterol J; 2020 May; 8(4):462-471. PubMed ID: 32213036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
    Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
    Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography.
    Enns R; Eloubeidi MA; Mergener K; Jowell PS; Branch MS; Baillie J
    Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
    Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
    Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group.
    van den Hazel SJ; Wolfhagen EH; van Buuren HR; van de Meeberg PC; Van Leeuwen DJ
    Endoscopy; 2000 Oct; 32(10):779-82. PubMed ID: 11068837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic retrograde cholangiopancreatography-related adverse events in patients with type 1 autoimmune pancreatitis.
    Naitoh I; Nakazawa T; Okumura F; Takada H; Hirano A; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Yamashita H; Sano H; Ohara H; Joh T
    Pancreatology; 2016; 16(1):78-82. PubMed ID: 26626204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective.
    Alkhatib AA; Hilden K; Adler DG
    Dig Dis Sci; 2011 Dec; 56(12):3685-8. PubMed ID: 21789539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
    Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
    Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications after ERCP in patients with primary sclerosing cholangitis.
    Etzel JP; Eng SC; Ko CW; Lee SD; Saunders MD; Tung BY; Kimmey MB; Kowdley KV
    Gastrointest Endosc; 2008 Apr; 67(4):643-8. PubMed ID: 18061595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antibiotic use to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis.
    Ishigaki T; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishii Y; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2015; 62(138):417-24. PubMed ID: 25916074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of antibiotic prophylaxis in routine endoscopic retrograde cholangiopancreatography investigations as assessed prospectively in a nationwide study cohort.
    Olsson G; Arnelo U; Lundell L; Persson G; Törnqvist B; Enochsson L
    Scand J Gastroenterol; 2015 Jul; 50(7):924-31. PubMed ID: 25769041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography.
    Inamdar S; Berzin TM; Berkowitz J; Sejpal DV; Sawhney MS; Chutanni R; Pleskow DK; Trindade AJ
    Liver Int; 2016 Oct; 36(10):1457-63. PubMed ID: 26913829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of endoscopic nasobiliary drainage for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones: experience from a Chinese center.
    Yang J; Peng JY; Pang EJ; Chen W
    Dig Endosc; 2013 Jul; 25(4):453-8. PubMed ID: 23363031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and reintervention after endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis in absence of cholangitis.
    Horio R; Kato J; Taida T; Ohta Y; Saito K; Oyama Y; Nakazawa H; Mamiya Y; Goto C; Takahashi S; Ouchi M; Kurosugi A; Sonoda M; Kan M; Kaneko T; Nagashima H; Akizue N; Takahashi K; Okimoto K; Ohyama H; Matsumura T; Ohno I; Kato N
    Indian J Gastroenterol; 2024 Oct; 43(5):1021-1029. PubMed ID: 38995523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis.
    Talwalkar JA; Angulo P; Johnson CD; Petersen BT; Lindor KD
    Hepatology; 2004 Jul; 40(1):39-45. PubMed ID: 15239084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.